ASM Global Unveils Ambitious Plan Transforming Its Global Venue Portfolio Into World’s Most Sustainable Collection
27.3.2023 16:00:00 EEST | Business Wire | Press release
ASM Global, through its corporate social responsibility platform, ASM Global Acts, and in partnership with Honeycomb Strategies, has announced a dramatic plan—the most aggressive in the live entertainment industry—to convert its portfolio into the most sustainable venues on Earth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230327005195/en/
Colorado Convention Center / Photo courtesy of ASM Global
Beginning this year ASM Global will dedicate its full resources to achieving measurable results throughout its businesses using the most comprehensive tracking system in the venue space—intended to reflect that scale and create substantial collective impact on every continent it operates.
The company working with its client partners already boasts the largest collection of certified green venues with over 40 and growing throughout the portfolio.
In making the announcement, ASM Global President and CEO Ron Bension said, “Our current portfolio of LEED-certified venues has set the standard, and we’re now raising the bar even higher.
“This entire program will be integrated into all of the relationships with our existing and future clients as part of our intrinsic ASM Global DNA.
“As we stated when we first partnered with Honeycomb Strategies last summer, demand from our established and newer clients for state-of-the-art sustainability innovations has been consistently increasing. We are now in a position to work with them and lead the industry in this incredibly important space.”
ASM Global has committed to the following for all its venues:
- Reduce energy consumption by 25% by 2030 from baseline year (2023).
- Achieve 20% of all energy consumed through renewable energy sources by 2025.
- Carbon neutral by 2050.
- Divert over 50% of waste overall by 2025.
- Eliminate single-use plastic in front of house by 2025.
- Reduce water consumption by 25% by 2030 from baseline year (2023).
- Award 50% of its reportable spend to suppliers adhering to its environmental purchasing policy by 2030.
- Increase plant-based menu options by 35% by 2024 within Savor (ASM Global’s food division) venues.
- Decrease food waste by 75% by 2026 within Savor venues.
Lindsay Arell, one of Honeycomb Strategies’ two principals, said, “The project has already begun. We’ve selected a group of pilot venues across size, type and continents that have begun reporting against the goals. The aim is to add additional venues at a fast pace to obtain important baseline information for 2023.”
“For almost 20 years, the Colorado Convention Center has been a leader on the live event sustainability front,” said John Adams, general manager of the Colorado Convention Center. “We are excited to be a pilot venue for this project as ASM Global expands this commitment to all of its venues worldwide.”
ASM Global has partnered with WeTrack, a SaaS company that provides planning, sustainability goals and operations solutions to some of the world’s biggest sports and entertainment brands including FIFA, IOC, Wimbledon, World Triathlon and many others. The WeTrack system has been developed to help customers track progress on sustainability, ESG and CSR initiatives.
ASM Global venue ambassadors will each have a system set up for them with common indicators that ASM Global wants to track along with venue goals specific to the community in which they operate.
Honeycomb Strategies’ recent major sustainability programs and projects include the Colorado Convention Center, Moscone Center, Philadelphia Eagles, SoFi Stadium, Minnesota Vikings, Barclays Center, Visit Denver, Greenbuild Conference and Expo, Natural Products Expo, and Sustainable Brands.
About ASM Global
ASM Global is the world’s leading producer of entertainment experiences. It is the global leader in venue and event strategy and management—delivering locally tailored solutions and cutting-edge technologies to achieve maximum results for venue owners. The company’s elite venue network spans five continents with a portfolio of more than 350 of the world’s most prestigious arenas, stadiums, convention and exhibition centers, and performing arts venues. Follow us on Facebook, Instagram, LinkedIn and Twitter. asmglobal.com
About Honeycomb Strategies
Honeycomb Strategies is a women-owned, B-Corp-certified sustainability consulting firm specializing in the hospitality, sport and event industries. We work with our clients to consider their business and environmental practices working together, not sacrificing one for the other. We believe when an organization is innovative and resourceful, it is successful. With decades of combined experience, we have enjoyed working with some of the most iconic and sustainable venues and events in the industry. Follow us on Instagram and LinkedIn. hcsustainability.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230327005195/en/
Contact information
Jim Yeager
breakwhitelight (for ASM Global)
jim@breakwhitelight.com
Mobile: 818-264-6812
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom